Compositions comprising cardiac stem cells overexpressing specific microRNAs and methods of their use in repairing damaged myocardium

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8497252
SERIAL NO

13487974

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compositions comprising modified stem cells containing a transgene that affects the expression of at least one gene that inhibits or promotes cardiomyogenesis. In particular, the invention discloses compositions comprising cardiac stem cells, wherein said cardiac stem cells comprise a transgene encoding a microRNA. The compositions of the invention find use in the treatment of cardiovascular disorders, such as myocardial infarction. Methods of repairing damaged myocardium in a subject using the modified stem cells are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NEW YORK MEDICAL COLLEGE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anversa, Piero Boston, US 38 908
Hosoda, Toru Chestnut Hill, US 11 119
Kajstura, Jan Brookline, US 14 347
Leri, Annarosa Boston, US 20 357

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00